{"id":"isobromindione","rwe":[],"tags":[{"label":"isobromindione","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"M04AB04","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"uridion","offLabel":[],"synonyms":["isobromindione","uridion"],"timeline":[],"approvals":[],"brandName":"Uridion","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"isobromindione","explanation":"Unfortunately, the exact mechanism of action of Uridion is not well understood, but it is thought to involve a complex interaction with a specific protein or receptor in the body. This interaction is believed to produce a therapeutic effect, but the details of how it works are not yet clear. More research is needed to fully understand how Uridion produces its effects.","oneSentence":"Uridion works by interacting with a specific target in the body to produce a therapeutic effect.","technicalDetail":"Uridion's mechanism of action is not well characterized, but it is thought to involve a specific interaction with a target protein or receptor, potentially leading to changes in ion channel function or neurotransmitter release."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1488","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ISOBROMINDIONE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:10:10.227635","biosimilars":[],"competitors":[{"drugName":"probenecid","drugSlug":"probenecid","fdaApproval":"1951-04-26","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulfinpyrazone","drugSlug":"sulfinpyrazone","fdaApproval":"1959-05-13","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"lesinurad","drugSlug":"lesinurad","fdaApproval":"2015-12-22","patentExpiry":"Nov 26, 2028","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"isobromindione","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"probenecid","brandName":"probenecid","genericName":"probenecid","approvalYear":"1951","relationship":"same-class"},{"drugId":"sulfinpyrazone","brandName":"sulfinpyrazone","genericName":"sulfinpyrazone","approvalYear":"1959","relationship":"same-class"},{"drugId":"lesinurad","brandName":"lesinurad","genericName":"lesinurad","approvalYear":"2015","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"J1J87P409K","CHEBI":"CHEBI:135275","INN_ID":"5563","UMLSCUI":"C1881274","ChEMBL_ID":"CHEMBL2104325","KEGG_DRUG":"D07279","DRUGBANK_ID":"DB13545","PUBCHEM_CID":"68953","MESH_SUPPLEMENTAL_RECORD_UI":"C009626"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"M04AB04","allCodes":["M04AB04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Uridion (isobromindione) is a small molecule drug in the isobromindione class, but information on its target and mechanism of action is not available. Its commercial status and approved indications are also unknown. As a result, there is limited information available on its safety profile and pharmacokinetic properties. Further research is needed to fully understand the characteristics of Uridion. Its development and ownership history are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}